Local OBGYN addresses the first FDA approved postpartum drug – KBTX

COLLEGE STATION, Tex. (KBTX)- The U.S. Food and Drug Administration approved the first drug developed to treat symptoms for severe postpartum depression in new mothers. Zulresso, developed by Sage Therapeutics, will be given through an IV over two and a half days, requiring a stay in a medical center. The drug is designed to mimic natural hormones that normally lower in a woman after childbirth According to clinical trials, the drug works within 48 hours, but is quite expensive, averaging out at $34,000 per patient, not including the two-day medical stay. Dr. Nancy Bertsch, an OBGYN at Baylor Scott & ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 6

Ähnlich Nachrichten